https://www.selleckchem.com/pr....oducts/eribulin-mesy
ree of delirium and coma (all p0·01). 601 (28·8%) of 2088 patients died within 28 days of admission, with most of those deaths occurring in the ICU. Acute brain dysfunction was highly prevalent and prolonged in critically ill patients with COVID-19. Benzodiazepine use and lack of family visitation were identified as modifiable risk factors for delirium, and thus these data present an opportunity to reduce acute brain dysfunction in patients with COVID-19. None. For the French and Spanish translations of the abstract
Like
Comment
Share
